Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1)

AIM: Talimogene laherparepvec (T-VEC) is an intralesional treatment for unresectable cutaneous, subcutaneous and nodal melanoma. COSMUS-1 was conducted to examine how T-VEC is used in US clinical practice. MATERIALS & METHODS: A chart review was conducted at seven centers, with 78 patients scree...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Melanoma Manag
Autors principals: Perez, Matthew C, Zager, Jonathan S, Amatruda, Thomas, Conry, Robert, Ariyan, Charlotte, Desai, Anupam, Kirkwood, John M, Treichel, Sheryl, Cohan, David, Raskin, Leon
Format: Artigo
Idioma:Inglês
Publicat: Future Medicine Ltd 2019
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6688558/
https://ncbi.nlm.nih.gov/pubmed/31406563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars